Shannon M Dunlay1, Jill M Killian2, Rozalina G Mccoy3, Margaret M Redfield4. 1. Department of Cardiovascular Medicine; Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. Electronic address: dunlay.shannon@mayo.edu. 2. Department of Quantitative Health Sciences. 3. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery; Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota. 4. Department of Cardiovascular Medicine.
Abstract
BACKGROUND: Diabetes mellitus is associated with increased rates of mortality in patients with less severe (stage C) heart failure (HF). The prevalence of diabetes and its complications in advanced (stage D) HF and their contributions to mortality risk are unknown. METHODS AND RESULTS: We conducted a retrospective population-based cohort study of all adult residents of Olmsted County, Minnesota, who had advanced HF between 2007 and 2017. Patients with diabetes were identified by using the criteria of the Healthcare Effectiveness Data and Information Set. Diabetes complications were captured by using the Diabetes Complications Severity Index. Of 936 patients with advanced HF, 338 (36.1%) had diabetes. Overall, median survival time after development of advanced HF was 13.1 (3.9-33.1) months; mortality did not vary by diabetes status (aHR 1.06, 95% CI 0.90-1.25; P = 0.45) or by glycated hemoglobin levels in those with diabetes (aHR 1.01 per 1% increase, 95% CI 0.93-1.10; P = 0.82). However, patients with diabetes and 4 (aHR 1.24, 95% CI 0.92-1.67) or 5-7 (aHR 1.49, 95% CI 1.09-2.03) diabetes complications were at increased risk of mortality compared to those with ≤ 3 complications. CONCLUSIONS: More than one-third of patients with advanced HF have diabetes. In advanced HF, overall prognosis is poor, but we found no evidence that diabetes is associated with a significantly higher mortality risk.
BACKGROUND: Diabetes mellitus is associated with increased rates of mortality in patients with less severe (stage C) heart failure (HF). The prevalence of diabetes and its complications in advanced (stage D) HF and their contributions to mortality risk are unknown. METHODS AND RESULTS: We conducted a retrospective population-based cohort study of all adult residents of Olmsted County, Minnesota, who had advanced HF between 2007 and 2017. Patients with diabetes were identified by using the criteria of the Healthcare Effectiveness Data and Information Set. Diabetes complications were captured by using the Diabetes Complications Severity Index. Of 936 patients with advanced HF, 338 (36.1%) had diabetes. Overall, median survival time after development of advanced HF was 13.1 (3.9-33.1) months; mortality did not vary by diabetes status (aHR 1.06, 95% CI 0.90-1.25; P = 0.45) or by glycated hemoglobin levels in those with diabetes (aHR 1.01 per 1% increase, 95% CI 0.93-1.10; P = 0.82). However, patients with diabetes and 4 (aHR 1.24, 95% CI 0.92-1.67) or 5-7 (aHR 1.49, 95% CI 1.09-2.03) diabetes complications were at increased risk of mortality compared to those with ≤ 3 complications. CONCLUSIONS: More than one-third of patients with advanced HF have diabetes. In advanced HF, overall prognosis is poor, but we found no evidence that diabetes is associated with a significantly higher mortality risk.
Authors: Shannon M Dunlay; Michael M Givertz; David Aguilar; Larry A Allen; Michael Chan; Akshay S Desai; Anita Deswal; Victoria Vaughan Dickson; Mikhail N Kosiborod; Carolyn L Lekavich; Rozalina G McCoy; Robert J Mentz; Ileana L PiÑa Journal: J Card Fail Date: 2019-06-05 Impact factor: 5.712
Authors: John J V McMurray; Scott D Solomon; Silvio E Inzucchi; Lars Køber; Mikhail N Kosiborod; Felipe A Martinez; Piotr Ponikowski; Marc S Sabatine; Inder S Anand; Jan Bělohlávek; Michael Böhm; Chern-En Chiang; Vijay K Chopra; Rudolf A de Boer; Akshay S Desai; Mirta Diez; Jaroslaw Drozdz; Andrej Dukát; Junbo Ge; Jonathan G Howlett; Tzvetana Katova; Masafumi Kitakaze; Charlotta E A Ljungman; Béla Merkely; Jose C Nicolau; Eileen O'Meara; Mark C Petrie; Pham N Vinh; Morten Schou; Sergey Tereshchenko; Subodh Verma; Claes Held; David L DeMets; Kieran F Docherty; Pardeep S Jhund; Olof Bengtsson; Mikaela Sjöstrand; Anna-Maria Langkilde Journal: N Engl J Med Date: 2019-09-19 Impact factor: 91.245
Authors: Rabea Asleh; Alexandros Briasoulis; Sarah D Schettle; Vakhtang Tchantchaleishvili; Naveen L Pereira; Brooks S Edwards; Alfredo L Clavell; Simon Maltais; David L Joyce; Lyle D Joyce; Richard C Daly; Sudhir S Kushwaha; John M Stulak Journal: Circ Heart Fail Date: 2017-11 Impact factor: 8.790
Authors: Maria G Crespo-Leiro; Marco Metra; Lars H Lund; Davor Milicic; Maria Rosa Costanzo; Gerasimos Filippatos; Finn Gustafsson; Steven Tsui; Eduardo Barge-Caballero; Nicolaas De Jonge; Maria Frigerio; Righab Hamdan; Tal Hasin; Martin Hülsmann; Sanem Nalbantgil; Luciano Potena; Johann Bauersachs; Aggeliki Gkouziouta; Arjang Ruhparwar; Arsen D Ristic; Ewa Straburzynska-Migaj; Theresa McDonagh; Petar Seferovic; Frank Ruschitzka Journal: Eur J Heart Fail Date: 2018-07-17 Impact factor: 15.534
Authors: Mark J Russo; Jonathan M Chen; Kimberly N Hong; Allan S Stewart; Deborah D Ascheim; Michael Argenziano; Donna M Mancini; Mehmet C Oz; Yoshifumi Naka Journal: Circulation Date: 2006-11-06 Impact factor: 29.690
Authors: Shannon M Dunlay; Véronique L Roger; Jill M Killian; Susan A Weston; Philip J Schulte; Anna V Subramaniam; Saul B Blecker; Margaret M Redfield Journal: JACC Heart Fail Date: 2021-08-11 Impact factor: 12.544
Authors: Hsien-Yen Chang; Jonathan P Weiner; Thomas M Richards; Sara N Bleich; Jodi B Segal Journal: Am J Manag Care Date: 2012-11 Impact factor: 2.229